copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
About Electromed | SmartVest Electromed develops, manufactures, and markets innovative airway clearance devices that help people around the world breathe better, stay healthier, and lead active and fulfilling lives
Investor Relations | SmartVest Electromed (NYSE American: ELMD) is a profitable and growing medical device company that develops, manufactures, markets and sells innovative High Frequency Chest Wall Oscillation (HFCWO) airway clearance products, primarily for use in the home setting
Electromed, Inc. (ELMD) - Yahoo Finance Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for
Bronchiectasis Airway Clearance Therapy | SmartVest Find relief from your chronic cough, recurring respiratory infections, and other bronchiectasis-related symptoms with SmartVest Request a packet to share with your doctor! Have questions now? Call our Patient Care Advocates, who are Respiratory Therapists, at (800) 462-1045 or request a call and see if SmartVest could be the right option for you
Electromed, Inc. Announces Record Financial Performance in Fiscal 2025 . . . NEW PRAGUE, Minn --(BUSINESS WIRE)-- Electromed, Inc (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six months ended December 31, 2024 (“Q2 FY 2025”)
Electromed, Inc. to Join Russell 2000® and Russell 3000® Indexes Electromed, Inc (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that the Company will join the small-cap Russell 2000 ® Index and the broad-market Russell 3000 ® Index, effective after the close of U S equity markets on June 27, 2025, as part of their 2025
Bronchiectasis COPD Support Resources | SmartVest Accredited by The Joint Commission, the Electromed team practices a patient-first culture that’s devoted to helping people living with bronchiectasis and other chronic lung conditions get back to enjoying life’s most important moments, one breath at a time
Electromed Recycling Dental Medical equipment Waste Collection, Disposal and Recycling All equipment carry serial numbers which are traceable
Home | Electromed ElectroMed is building a sensing platform with in-situ peptide synthesis that could overcome these issues We have based our proposal on reliable silicon technology using Field Effect Transistors, which can be integrated in a fully automated electrochemical system